There is considerable interest in the interactions of ruthenium (Ru)(II) complexes with DNA as well as the biological impact of the interactions. Here, by using isothermal titration calorimetry, viscosity measurement, and circular dichroism, we investigated the interactions of a new Ru ( Our data demonstrated that the Ru(II) polypyridyl complex binds to DNA and thereby induces apoptosis in tumor cells, suggesting that anti-tumor activity of the Ru(II) complex could be related to its interaction with DNA.
Introduction
There is considerable interest in the interactions of ruthenium Ru(II) complexes with DNA as well as the biological impact of the interactions [1] [2] [3] [4] [5] [6] [7] . Ru(II) complexes are usually used as DNA structural probes, artificial nucleases, DNA molecular light switches, and DNA-targeting drugs [1] [2] [3] [4] [5] . Researches on anti-tumor active platinum complexes have always been a stimulating topic in decades [4, 8, 9] . Some Ru(II) complexes are structural analogues of transplatinum and cisplatin complexes and show promising antitumor activity [10, 11] . Although the cytotoxicity of some Ru(II) complexes to tumor cells has been reported [10] [11] [12] [13] , the potential ability of Ru(II) complexes inducing apoptosis in tumor cells has been little documented.
In recent years, isothermal titration calorimetry (ITC) has become a widely used method for understanding molecular recognition within cells [14] [15] [16] [17] [18] . This method has yielded some useful thermodynamic data on the interactions of metal complexes with DNA [7, 17, 18] , and assessing drug -DNA interaction is of great importance for drug development. In the present study, we employed ITC, viscosity measurement, equilibrium dialysis, and circular dichroism (CD) to investigate the interaction of a new Ru(II) complex, [Ru(dmp) 2 PMIP] 2þ {dmp ¼ 2,9-dimethyl-1,10-phenanthroline, PMIP ¼ 2-(4-methylphenyl)imidazo [4,5- f ]1,10-phenanthroline} ( Fig. 1) , a structural analogue of platinum complex, with calf thymus DNA (CT DNA), and then investigated the impact of the Ru(II) complex on human lung cancer cells A549, in order to further understand the binding mechanism and the biological impact of the interactions. The Ru(II) complex contains a PMIPintercalating ligand and two dmp (2,9-dimethyl-1,10-phenanthroline) ancillary ligands. Because of the steric hindrance exerted by the methyl groups located at such ligands, we speculated that complex [Ru(dmp) 2 
should be a moderate intercalative complex. The experimental results indicated that the Ru(II) complex and CT DNA formed a tight 1:1 complex with a binding constant exceeding 10 6 M 21 and with a binding mode of intercalation, and suggested that anti-tumor activity of the Ru(II) complex could be related to its interaction with DNA.
Materials and Methods
Materials CT DNA (Sigma-Aldrich, St Louis, USA) was dissolved in the corresponding buffer with appropriate concentration and stored at 48C, then used not more than 1 day. CT DNA was purified by ethanol precipitation and centrifugal dialysis before use. The concentration of CT DNA solution was determined spectroscopically at 260 nm using a molar extinction coefficient of 6600 M 21 cm
21
[19] and expressed as base concentrations throughout this paper. In all experiments, unless otherwise specified, CT DNA samples 20,000 bp in average length were employed. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), trypan blue dye, propidium iodide (PI), and RNase were purchased from Sigma-Aldrich. All other chemicals used were made in China and of analytical grade. TrisHCl buffer (5 mM, pH 7.2) containing 50 mM NaCl was used for viscosity measurements and CD spectroscopic studies. Because the heat effects of ionization and dilution of Tris -HCl buffer were too large to measure the binding heat effect exactly, 20 mM HEPES (Amresco Chemical Co., Solon, USA) buffer, pH 7.2, containing 0.1 mM EDTA was used for ITC experiments.
Synthesis of [Ru(dmp) 2 [20] . PMIP was synthesized by a method similar to that described previously [21] . Briefly, a mixture of 4-methylbenzaldehyde (3.5 mmol, 0.41 ml), 1,10-phenanthroline-5,6-dione (2.5 mmol, 0.525 g), ammonium acetate (50 mmol, 3.88 g), and glacial acetic acid (10 ml) was refluxed for about 2 h, cooled to room temperature, and diluted with water (about 25 ml). Dropwise addition of concentrated aqueous ammonia gave yellow precipitates, which were collected and washed with water. The crude products were purified by silica gel filtration (60-100 mesh, ethanol). The principal yellow band was collected. The solvent was removed by rotary evaporation, and the products were collected and dried at 508C in vacuo. Yield was 0.464 g, 60%.
Complex [Ru(dmp) 2 [22] as Equations (1) and (2):
The molar heat capacity change associated with the binding of Ru(II) complex to CT DNA ðD b C P;m Þ was obtained by linear regression analysis of the plots by DNA binding, cytotoxicity, and apoptotic-inducing activity of Ru(II) complex respectively. Here, DH 0 and DS 0 are constants of linear fitting.
Viscosity measurements
Viscosity experiments were carried out using an Ubbelodhe viscometer (Sangli, Nanjing, China) maintained at 25.0(+0.1)8C in a thermostatic water-bath. Rod-like CT DNA samples 200 bp in average length were prepared by sonication in order to minimize complexities arising from DNA flexibility [23] . Flow time was measured with a digital stopwatch, each sample was measured three times, and an average flow time was calculated. Data were presented as (h/h 0 ) 1/3 vs. binding ratio [24] , where h is the viscosity of CT DNA in the presence of the Ru(II) complex and h 0 the viscosity of CT DNA alone.
Equilibrium dialysis and CD spectroscopy
Equilibrium dialyses were conducted with 5 ml of CT DNA (1.0 mM) sealed in a dialysis bag and 15 ml of complex (100 mM) outside the bag at 48C. CD spectra of dialyzates of the complex were measured on a Jasco J-810 spectropolarimeter (Jasco Corporation, Tokyo, Japan) using a 0.1-cm path length cell at 258C. The region between 220 and 350 nm was scanned for each sample three times. Blank controls of the complex were taken and no obvious signals were observed.
Cell viability assays
Human lung cancer cell line A549 and human embryonic lung fibroblast diploid normal cell line MRC-5 were cultured in Dulbecco's modified Eagle's medium (Thermo Scientific HyClone, Logan, USA) supplemented with 10% (v/v) fetal bovine serum (FBS) in 5% CO 2 atmosphere at 378C, respectively. For cell viability assay, the cancer cells were plated at a density of 10 4 cells/well in 96-well plates (Iwaki; Asahi Technoglass, Gyouda, Japan) and incubated for 24 h. The medium was removed, and [Ru(dmp) 2 PMIP] 2þ solutions were added into a new medium without FBS to the required final concentrations between 10 and 200 mM. The untreated A549 cells were used as a control.
After 72 h of incubation, 10 ml of a stock MTT solution was added to give a final concentration of 0.5 mg/ml and incubated for a further 4 h. Then, the medium was replaced with 100 ml of pure dimethyl sulfoxide and the absorbance of the dark blue formazan was measured with an ELISA plate reader at 570 nm. Cell viability ¼ (A sample /A control ) Â 100%. MRC-5 cells were used as a control and treated by complex [Ru(dmp) 2 PMIP] 2þ with the same procedures. After 72 h of incubation with complex [Ru(dmp) 2 
PMIP]
2þ , 30 ml of washed cell suspension was mixed thoroughly with 30 ml of trypan blue solution (0.4%) and allowed to stand for 3 min at room temperature. The total number of cells and the number of blue-stained cells (dead cells) were counted on a hemocytometer, using a microscope.
DNA content assay DNA content was assayed as described previously [25] . Briefly, cells were treated with complex [Ru(dmp) 2 
for 72 h, then collected at a density of 10 6 cells/plate, rinsed with PBS buffer, and re-suspended in 70% ethanol overnight at 48C. After centrifugation at 1000 rpm for 5 min, the samples were washed with PBS buffer twice, incubated in 1 ml PBS buffer (containing 50 mg/ml RNase, 378C, 30 min), and then PI solution was added to cell suspensions to a final concentration of 50 mg/ml (dark, 48C, 30 min). After filtration through a layer of 200-mesh silk screen, stained cells were analyzed on EPICS XL-MCL flow cytometer (Beckman Coulter, Fullerton, USA). The percentage of apoptotic cells was estimated using CellQuest program (Becton Dickinson, Franklin Lakes, USA).
Annexin V-FITC apoptosis detection assay Apoptotic cells were detected by flow cytometry after staining with annexin V-FITC and PI using the annexin V-FITC apoptosis detection kit (BioVision, Mountain View, USA) as described previously [25] . Briefly, cells were treated with complex [Ru(dmp) 2 PMIP] 2þ for 72 h, collected, washed with PBS buffer, and re-suspended in 500 ml of binding buffer containing 5 ml annexin V-FITC and 10 ml PI. After 5 min of incubation in darkness at room temperature, annexin V binding was analyzed by EPICS XL-MCL flow cytometer equipped with a FITC signal detector FL1 (excitation ¼ 488 nm, green) and a PI signal detector FL2 (excitation ¼ 488 nm, red). The percentage of apoptotic cells was calculated from the total ( 10 4 cells) using EXPO32 MultiComp software (Beckman Coulter).
Statistical analysis
Data were expressed as mean + SD of six to eight independent experiments. Statistical analyses were performed using Student's t-test. Values of P , 0.05 were considered to be statistically significant. The following notation was used throughout: *P , 0.05 and **P , 0.01, relative to control. Figure 2 (A) shows the ITC curves resulting from the injections of the Ru(II) complex into a solution of CT DNA at 258C. The titration curves displayed that the binding reactions for CT DNA was exothermic, resulting in negative peaks in the plots of power vs. time. Table 1 . As shown in Table 1 , the Ru(II) complex showed a strong and temperature-dependent binding affinity to CT DNA, and the binding constant decreased remarkably with the increase in the temperatures from 20.0 to 37.08C. The binding of the complex to CT DNA was enthalpy-and entropy-driven reaction. Furthermore, the binding of complex [Ru(dmp) 2 
Results

DNA-binding properties
to CT DNA showed strong temperature dependence of entropy and enthalpy changes and weak temperature dependence of Gibbs free energy change. From Table 1 , it can also be seen that each complex bound to about two DNA bases. We have demonstrated that each of its analogue complex, [Ru( phen) 2 PMIP] 2þ , binds to about three DNA bases [7] . We suggested that the four methyl groups in the ancillary ligand of complex [Ru(dmp) 2 PMIP] 2þ resulted in such a difference. Figure 3 shows the temperature dependence of the standard thermodynamic parameters for the interaction of complex [Ru(dmp) 2 Viscosity and CD spectroscopic studies As shown in Fig. 4 , the relative specific viscosity of DNA increased steadily with the increase in the concentration of Ru(II) complex, mainly for the lengthening of the DNA double helix resulting from intercalation [26, 27] . Figure 5 shows the CD spectra in the UV region of the Ru(II) complex after its racemic solution had been dialyzed against CT DNA. As shown in Fig. 5 , dialyzate of the Ru(II) complex showed two obvious CD signals, one is a positive peak at about 250 nm and the other is a negative peak at about 285 nm, indicating that the complex enantioselectively interacted with CT DNA.
Cytotoxicity studies
The cytotoxicity of complex [Ru(dmp) 2 PMIP] 2þ to human lung tumor cells of A549 was measured by MTT reduction assay [28] . The metabolic activity of the cells was assessed by their ability to cleave the tetrazolium rings of the pale yellow MTT and form a dark blue water-insoluble formazan crystal. Figure 6 shows the results of the cell viability experiments aimed at determining the cytotoxicity of complex [Ru(dmp) 2 PMIP] 2þ . As shown in Fig. 6(A) , complex [Ru(dmp) 2 PMIP] 2þ showed significant dosedependent cytotoxicity to human lung carcinoma cells of A549.
Because a potential anticancer drug candidate should selectively affect only tumor cells and not somatic cells [29] , the cytotoxicity of complex [Ru(dmp) 2 PMIP] 2þ to the normal diploid embryonic lung cell line (MRC-5) was also measured by MTT reduction assay. The complex showed preferential cytotoxicity to human lung tumor cells of A549 [ Fig. 6(A) ] vs. human lung normal cells of MRC-5 [ Fig. 6(B) ], indicating that the cytotoxic Ru(II) complex could be a potential anti-tumor drug.
We further employed trypan blue exclusion assay [30] Viable cells characterized by a structurally integral cell membrane do not uptake trypan blue dye. In contrast, dead cells (necrotic or late apoptotic cells) characterized by the loss of integrity of their membrane are stained blue by the dye [25, 30] . At all concentrations tested, the Ru(II) complex reduced the number of viable A549 cells after staining with trypan blue at 72 h (effects on cell proliferation), which was much more evident at higher concentrations (120 -200 mM) (data not shown), further supporting the conclusion reached by MTT reduction assay that such a complex shows significant dosedependent cytotoxicity to A549 cells.
Apoptosis activity
Apoptotic cells show a reduced DNA content below the G0/G1 level. When apoptotic cells are stained by PI and analyzed by a flow cytometer, they display a broad hypodiploid (sub-G1) peak. Sub-G1 peak is one of the reliable biochemical markers of apoptosis [31] , although the presence of a hypodiploid DNA peak is not a bona fide proof of apoptotic death [32] . Cytometric cell cycle analysis was performed by staining cells with PI and apoptosis was estimated by CellQuest program. Fig. 7(B) ] and in MRC-5 cell line treated by the complex at the same concentration [1.2%, Fig. 7(C) ]. The DNA content frequency distribution histograms clearly indicated that the exposure of cells to the Ru(II) complex resulted in the appearance of cells with a fractional DNA content, which is defined as sub-G1 peak [ Fig. 7(A) ]. The above results indicated the cytotoxic Ru(II) complex induces apoptosis of human lung cancer cell line A549. peak is clearly evident in (A). The phases of the cell cycle from the left to the right were sub-G1-phase, G0/G1-phase, S-phase, and G2/M-phase.
In the early stages of apoptosis, the cell membrane can expose phosphatidylserine which is annexin V-positive [32] . Phosphatidylserine externalization not only takes place in apoptosis, but also occurs during cell necrosis. The difference between these two forms of cell death is that during the early stages of apoptosis, the cell membrane remains intact, whereas at the very moment that necrosis occurs, the cell membrane looses its integrity and becomes leaky [33] . Therefore, the measurement of annexin V binding to the cell surface as indicative for apoptosis has to be performed in conjunction with a dye exclusion test to establish integrity of the cell membrane [33] . In combination with the membrane-impermeable DNA stain PI, with a flow cytometer, one can distinguish at least three different cell types during apoptosis: viable cells (annexin V-and PI-negative), early apoptotic cells (annexin V-positive but PI-negative), and necrotic or late apoptotic cells (annexin V-and PI-positive) [33, 34] . In order to distinguish between apoptosis and necrosis, we performed double staining using annexin V-FITC and PI followed by flow cytometry. 
Discussion
This study presented a detailed thermodynamic investigation on DNA binding of a Ru(II) complex containing a PMIP-intercalating ligand and two 2,9-dimethyl-1,10-phenanthroline ancillary ligands. Generally, thermodynamicbinding studies alone cannot establish the binding modes of a metal complex, so hydrodynamic studies, such as viscosity, sedimentation, and binding effects on DNA supercoiling, that are sensitive to length change and regarded as the most classical methods are needed to elucidate the intercalation modes of the octahedral complex [Ru(dmp) 2 PMIP] 2þ to CT DNA. In this way, the viscosity measurement was carried out on CT DNA by varying the concentration of the Ru(II) complex. As expected, such a complex increased the relative specific viscosity of CT DNA steadily for the lengthening of the DNA double helix through the intercalation mode. Therefore, we concluded that complex [Ru(dmp) 2 PMIP] 2þ intercalated into CT DNA base pairs in a way shown in Fig. 9 . The role of Ru(II) here is to form a stable complex with a PMIP-intercalating ligand and two dmp ancillary ligands, accompanied by rich photophysical properties.
Molar heat capacity changes occurred in the binding reactions of biological molecules originate from the variations in non-polar and polar areas exposed to the solvent [18] . Both the standard molar enthalpy change and the standard molar entropy change for the binding strongly depended on temperature, yielding a negative molar heat capacity change of 2331.8 cal mol 21 K 21 (average of the values from Fig. 3 ). Negative molar heat capacity change of the reaction demonstrated the burial of hydrophobic and hydrophilic solvent-accessible surface of CT DNA [35] upon interaction with the Ru(II) complex. Because of the presence of four methyl groups in the octahedral complex, to CT DNA can be observed clearly from CD spectra. The presence of CD signals indicates enrichment of the enantiomer binding less favorably to CT DNA. From our CD experiments, we may deduce that although such a Ru(II) complex has not been resolved into its pure enantiomers, and we cannot determine which enantiomer binds to CT DNA enantioselectively experimentally, it is certain that the same isomer of the complex has a special preference for CT DNA binding. Barton [36] has brought forward the binding model that the D enantiomer of a metal complex will display a greater binding affinity with the right-handed CT DNA helix than the L enantiomer. Therefore, we deduce that the D enantiomer of the complex could bind more favorably to CT DNA and may be more effective for the cytotoxic action than the L enantiomer does. Transition metal-based compounds such as Ru(II) complexes constitute a discrete class of chemotherapeutics, which are now used in the clinic as anti-tumor agents [4, 5] . In the field of non-platinum compounds exhibiting anticancer properties, Ru(II) complexes are promising, showing activity on tumors which developed resistance to cisplatin or in which cisplatin is inactive [37, 38] . Although the pharmacological target for Ru(II) compounds has not been unequivocally identified, there is a body of evidence indicating that the anti-tumor activity of Ru(II) complexes correlates with their ability to bind to DNA [13] . In the present study, complex [Ru(dmp) 2 PMIP] 2þ bound to CT DNA with a strong and temperature-dependent binding affinity. The Ru(II) complex showed significant dosedependent cytotoxicity to human lung tumor cells and induced apoptosis of human lung cancer cell line. But normal lung cells of MRC-5 were only slightly affected by the interaction of the Ru(II) complex with DNA in contrast to A549 tumor cells in the presence of the Ru(II) complex. It has been reported that the quercetin zinc(II) complex [39] , hedamycin [40] , and tris(tetramethylphenanthroline) Ru(II) [41] intercalate into the GC-rich core promoter region of survivin, down-regulating surviving gene expression and promoting tumor cells apoptosis. Therefore, we deduced that the Ru(II) complex intercalated into DNA and thereby induced apoptosis in tumor cells. It would be worthwhile to extend the current work to analyze caspase activation and/or the release of cytochrome c from mitochondria, typical of apoptotic cell death [42] . These are planned for the future.
In conclusion, we have investigated the interaction of the Ru(II) polypyridyl complex with CT DNA by using several biophysical methods and found that the complex intercalates into CT DNA, and hydrophobic and hydrophilic solvent-accessible surface of CT DNA is buried on complexation. Cell viability experiments indicate that the Ru(II) complex exhibits significant dose-dependent cytotoxicity to human lung tumor cells of A549. Further flow cytometry experiments show that the cytotoxic Ru(II) complex induces apoptosis of human lung cancer cell line A549. Our data demonstrate that the Ru(II) polypyridyl complex strongly binds to DNA and thereby induces apoptosis in tumor cells, suggesting that anti-tumor activity of the Ru(II) complex could be related to its interaction with DNA. Information obtained from this study will be helpful for designing new transition metal complexes used as potential anti-tumor drugs. 
